PPARG and Insulin resistance: Interference with cell metabolism by Tregs expressing PPARγ could inhibit adipose tissue inflammation in obese patients, and thus, Tregs may become a new target for the prevention and treatment of inflammation and insulin resistance (Hamaguchi and Sakaguchi, 2012).